Skip to content

Coherence Imaging of the Cervical Epithelium With Scanning a/LCI

Coherence Imaging of the Cervical Epithelium With Scanning a/LCI

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03502798
Enrollment
45
Registered
2018-04-19
Start date
2018-11-08
Completion date
2020-02-14
Last updated
2021-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Dysplasia

Brief summary

The purpose of this study is to develop a low coherence interferometry (LCI) endoscopic probe that can examine the cervix for evidence of cervical dysplasia. The device will make optical measurements of the cervix to determine: 1. the difference between two different types of cervical cells: ectocervical cells and endocervical cells. Cervical dysplasia is most likely to occur at the junction between these two types of cells. 2. features of individual cervical cells that indicate whether the cell is normal or abnormal (cervical dysplasia).

Interventions

DEVICEscanning a/LCI

Imaging of the cervical epithelium using the scanning a/LCI device.

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Jacobi Medical Center
CollaboratorOTHER
Duke University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* able to provide informed consent * willing to abstain from sexual intercourse for at least 24 hours before study visit

Exclusion criteria

* pregnant * have a current gynecological infection or discharge * have had any cervical surgery * had medical or cosmetic surgery involving the reproductive organs or genitals within the past 6 months * currently enrolled in any research studies involving the application of vaginal formulations * employed or supervised by the study investigators * have any other condition, that, in the opinion of the study clinician, would contraindicate participation in the study

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity of Scanning a/LCI Probe to Detect Cervical Dysplasia as Measured by Percentage of Correctly Identified Positive BiopsiesbaselineSensitivity of the scanning a/LCI probe's ability to detect cervical dysplasia determined by calculating the percentage of correctly identified positive optical biopsies measured by the scanning a/LCI probe when compared to the gold standard, histopathology. There are two dichotomies of classification used in this study: one that focuses on the morphological differences between cells (histology-based classification), and one that focuses on the urgency of corresponding treatment (response-based classification). In the histology-based classification, a result of benign alone is a negative result and a result of LSIL (low-grade squamous intraepithelial lesion) or HSIL (high-grade squamous epithelial lesion) is a positive result. In the response-based classification, both benign and LSIL are treated as negative results and HSIL is treated as a positive result.
Specificity of Scanning a/LCI Probe to Detect Cervical Dysplasia as Measured by Percentage of Correctly Identified Negative Optical BiopsiesbaselineSpecificity of the scanning a/LCI probe's ability to detect cervical dysplasia determined by calculating the percentage of correctly identified negative optical biopsies measured by the scanning a/LCI probe when compared to the gold standard, histopathology. There are two dichotomies of classification used in this study: one that focuses on the morphological differences between cells (histology-based classification), and one that focuses on the urgency of corresponding treatment (response-based classification). In the histology-based classification, a result of benign alone is a negative result and a result of LSIL (low-grade squamous intraepithelial lesion) or HSIL (high-grade squamous intraepithelial lesion) is a positive result. In the response-based classification, both benign and LSIL are treated as negative results and HSIL is treated as a positive result.

Secondary

MeasureTime frameDescription
Identification of T-zone by Scanning a/LCI ProbebaselineAbility of scanning a/LCI probe to correctly identify transformation zone (T-zone) compared to colpophotography

Countries

United States

Participant flow

Participants by arm

ArmCount
Scanning a/LCI (Pilot)
Pilot study conducted at Duke University (Durham, NC). Exclusion criteria included: current gynecological infection or discharge, prior cervical surgery, or positive urine pregnancy test. The scanning a/LCI probe was inserted into the vagina and placed against the cervix using direct visualization provided by a white light camera incorporated into the probe. Optical interferometric data were acquired to characterize the instrument's ability to detect cervical dysplasia via depth-resolved nuclear morphology measurements.
5
Scanning a/LCI (Jacobi)
Primary arm of present study, conducted at New York City Health + Hospitals / Jacobi (Bronx, New York, NY). Exclusion criteria included: current gynecological infection or discharge, prior cervical surgery, or positive urine pregnancy test. In addition, participants abstained from sexual intercourse for at least 24 hours prior to the study visit. A speculum was inserted prior to the a/LCI probe for ease of tissue biopsy collection after a/LCI scanning. The scanning a/LCI probe was inserted through speculum and placed against the cervix using white light visual guidance from the probe's integrated camera. The a/LCI imaging sequence was initiated, with 36 scan points spaced across an area of 50 mm2. 80 a/LCI optical biopsy scans were at 4 selected biopsy sites (20 per quadrant). The a/LCI probe was removed and a Wallach colposcope was used to take a digital image of the cervix for co-registration with the a/LCI image. Some women underwent a previously scheduled loop electrosurgical excision procedure (LEEP) immediately following data collection; tissue biopsies were taken either with the assistance of the colposcope or during the LEEP and all specimens were analyzed by pathologists to provide a histological diagnosis for comparison with the a/LCI measurements. Tissue biopsies for each quadrant were assigned a classification (negative, CIN-1, CIN-2, or CIN-3) as well as notes for any additional findings (koilocytic atypia, abnormal acetowhite epithelium, etc.).
40
Total45

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall Studyequipment failure07

Baseline characteristics

CharacteristicTotalScanning a/LCI (Jacobi)Scanning a/LCI (Pilot)
Age, Continuous34 years35 years26 years
Ethnicity (NIH/OMB)
Hispanic or Latino
23 Participants23 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
19 Participants14 Participants5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
3 Participants3 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
2 Participants1 Participants1 Participants
Race (NIH/OMB)
Black or African American
13 Participants11 Participants2 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
11 Participants11 Participants0 Participants
Race (NIH/OMB)
White
19 Participants17 Participants2 Participants
Sex: Female, Male
Female
45 Participants40 Participants5 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 50 / 40
other
Total, other adverse events
0 / 50 / 40
serious
Total, serious adverse events
0 / 50 / 40

Outcome results

Primary

Sensitivity of Scanning a/LCI Probe to Detect Cervical Dysplasia as Measured by Percentage of Correctly Identified Positive Biopsies

Sensitivity of the scanning a/LCI probe's ability to detect cervical dysplasia determined by calculating the percentage of correctly identified positive optical biopsies measured by the scanning a/LCI probe when compared to the gold standard, histopathology. There are two dichotomies of classification used in this study: one that focuses on the morphological differences between cells (histology-based classification), and one that focuses on the urgency of corresponding treatment (response-based classification). In the histology-based classification, a result of benign alone is a negative result and a result of LSIL (low-grade squamous intraepithelial lesion) or HSIL (high-grade squamous epithelial lesion) is a positive result. In the response-based classification, both benign and LSIL are treated as negative results and HSIL is treated as a positive result.

Time frame: baseline

Population: 40 women enrolled at the Jacobi site, but successful a/LCI scans were only acquired from 20 participants due to equipment failures (mechanical breaks in probe, electrical component failures, software errors). For each participant analyzed, optical biopsies (a/LCI scans) and corresponding physical tissue biopsies were collected at four sites (12, 3, 6, and 9 o'clock). No pilot study participants were analyzed as no physical tissue biopsies were done in the pilot phase.

ArmMeasureGroupValue (NUMBER)
Scanning a/LCI (Jacobi)Sensitivity of Scanning a/LCI Probe to Detect Cervical Dysplasia as Measured by Percentage of Correctly Identified Positive Biopsieshistology-based classification90.3 percentage of correct identifications
Scanning a/LCI (Jacobi)Sensitivity of Scanning a/LCI Probe to Detect Cervical Dysplasia as Measured by Percentage of Correctly Identified Positive Biopsiesresponse-based classification100.0 percentage of correct identifications
Primary

Specificity of Scanning a/LCI Probe to Detect Cervical Dysplasia as Measured by Percentage of Correctly Identified Negative Optical Biopsies

Specificity of the scanning a/LCI probe's ability to detect cervical dysplasia determined by calculating the percentage of correctly identified negative optical biopsies measured by the scanning a/LCI probe when compared to the gold standard, histopathology. There are two dichotomies of classification used in this study: one that focuses on the morphological differences between cells (histology-based classification), and one that focuses on the urgency of corresponding treatment (response-based classification). In the histology-based classification, a result of benign alone is a negative result and a result of LSIL (low-grade squamous intraepithelial lesion) or HSIL (high-grade squamous intraepithelial lesion) is a positive result. In the response-based classification, both benign and LSIL are treated as negative results and HSIL is treated as a positive result.

Time frame: baseline

Population: 40 women enrolled at the Jacobi site, but successful a/LCI scans were only acquired from 20 participants due to equipment failures (mechanical breaks in probe, electrical component failures, software errors). For each participant analyzed, optical biopsies (a/LCI scans) and corresponding physical tissue biopsies were collected at four sites (12, 3, 6, and 9 o'clock). No pilot study participants were analyzed as no physical tissue biopsies were done in the pilot phase.

ArmMeasureGroupValue (NUMBER)
Scanning a/LCI (Jacobi)Specificity of Scanning a/LCI Probe to Detect Cervical Dysplasia as Measured by Percentage of Correctly Identified Negative Optical Biopsieshistology-based classification81.6 percentage of correct identifications
Scanning a/LCI (Jacobi)Specificity of Scanning a/LCI Probe to Detect Cervical Dysplasia as Measured by Percentage of Correctly Identified Negative Optical Biopsiesresponse-based classification70.6 percentage of correct identifications
Secondary

Identification of T-zone by Scanning a/LCI Probe

Ability of scanning a/LCI probe to correctly identify transformation zone (T-zone) compared to colpophotography

Time frame: baseline

Population: Data not collected due to frequent instrument repairs.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026